A review of our peer-reviewed research, in the healthcare and mainstream press.
Studies from the current issue of The American Journal of Managed Care have been cited frequently this week.
New research from the CVS Health Research Institute was one of the most-cited articles this week. The study found that interventions to keep patients with common chronic conditions on their medication are very cost effective, especially if those interventions target patients who take 3 or more medications. Payers can save between $38 million and $63 million per 100,000 members by focusing on these patient populations. Multiple outlets cited the study, including The Pharmacist, the official publication of the American Pharmacist Association.
In addition, the Center for Infectious Disease Research and Policy at the University of Minnesota discussed an article by CDC authors, who found that more than three-fourths of adults diagnosed as having bronchitis receive an antibiotic, even though antibiotics are not indicated for this condition.
Promoting Health Equity and Resiliency in Trauma-Affected Communities
January 31st 2023On this episode of Managed Care Cast, we speak with Reverend Paul Abernathy, CEO of the Neighborhood Resilience Project and board member of UPMC for You, who discusses his experiences in promoting health and resiliency in trauma-affected communities, as well as challenges related to access and accessibility of care and medical mistrust.
Listen
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
Periostin Bests Eosinophil Count for Biomarker Predictability in ECRS
February 2nd 2023Known to be a contributing factor to polyp development at high levels, periostin’s potential as a biomarker for eosinophilic chronic rhinosinusitis (ECRS) severity was investigated in a new study in which outcomes were compared between patients who had ECRS and those with non-ECRS.
Read More
International Panel Forms Consensus Best Practices for Active Surveillance in Prostate Cancer
February 1st 2023Health care expert and lived experience panels came to a consensus on several aspects that should be considered in the decision to offer and continue active surveillance for prostate cancer.
Read More
2 Clarke Drive
Cranbury, NJ 08512